Cite
Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients
MLA
Florence Gattacceca, et al. Concentration–response Model of Rilpivirine in a Cohort of HIV-1-Infected Naive and Pre-Treated Patients. July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a065712ddc9cdfe2d027b27f76c411ea&authtype=sso&custid=ns315887.
APA
Florence Gattacceca, Nadège Néant, Caroline Solas, Gilles Peytavin, Diane Descamps, Catherine Dhiver, Yazdan Yazdanpanah, Bruno Lacarelle, Naïm Bouazza, Minh Patrick Lê, Catherine Tamalet, Saadia Mokhtari, & Sylvie Bregigeon. (2019). Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients.
Chicago
Florence Gattacceca, Nadège Néant, Caroline Solas, Gilles Peytavin, Diane Descamps, Catherine Dhiver, Yazdan Yazdanpanah, et al. 2019. “Concentration–response Model of Rilpivirine in a Cohort of HIV-1-Infected Naive and Pre-Treated Patients,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a065712ddc9cdfe2d027b27f76c411ea&authtype=sso&custid=ns315887.